Shanghai No.1 Pharmacy Co.,Ltd. (SHA:600833)
11.42
-0.26 (-2.23%)
Apr 17, 2026, 3:00 PM CST
Shanghai No.1 Pharmacy Revenue
In the year 2025, Shanghai No.1 Pharmacy had annual revenue of 2.13B CNY with 11.23% growth. Shanghai No.1 Pharmacy had revenue of 591.16M in the quarter ending December 31, 2025, with 8.22% growth.
Revenue
2.13B
Revenue Growth
+11.23%
P/S Ratio
1.22
Revenue / Employee
2.49M
Employees
856
Market Cap
2.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.13B | 215.08M | 11.23% |
| Dec 31, 2024 | 1.92B | 95.64M | 5.26% |
| Dec 31, 2023 | 1.82B | -836.39M | -31.49% |
| Dec 31, 2022 | 2.66B | 1.26B | 89.94% |
| Dec 31, 2021 | 1.40B | -188.62M | -11.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DaShenLin Pharmaceutical Group | 26.83B |
| Yifeng Pharmacy Chain | 24.13B |
| LBX Pharmacy Chain Joint Stock Company | 22.20B |
| Luyan Pharma | 20.91B |
| Cachet Pharmaceutical | 19.53B |
| Yixintang Pharmaceutical Group | 17.41B |
| ShuYu Civilian Pharmacy Corp. | 9.94B |
| Jianzhijia Pharmaceutical Chain Group | 9.10B |